BioPharma & Healthcare Related News

Isogenica Announces New Licence Agreement with Maverick Therapeutics

CAMBRIDGE, England--(BUSINESS WIRE)--Isogenica Ltd, a leader in the design and construction of innovative and highly diverse synthetic antibody libraries, today announced a new licensing deal with Maverick Therapeutics, a private start-up biotechnology company utilising a proprietary T-cell engagement format for [...]

By | February 7th, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Press Releases|

Meet the Speakers: Will Synthetic Biology be the Key to Our Future Health?

SynBioBeta’s fifth annual London conference is fast approaching, with leaders in industry, academia, and investment once again set to converge on Imperial College London between April 4th and 6th. A full schedule of exciting events and sessions has been lined [...]

By | February 1st, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Therapeutics|

Exemplar Genetics Awarded Subcontract to Advance New Therapeutic Models for Sickle Cell Disease

SIOUX CENTER, Iowa, Jan. 26, 2017 /PRNewswire/ -- Exemplar Genetics, a wholly owned subsidiary of Intrexon Corporation (NYSE: XON) committed to enabling the study of life-threatening human diseases, has been awarded a subcontract to create genetically engineered miniswine models of sickle [...]

By | January 30th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Bactevo Wins Innovate Award

Cambridge UK, 25th January 2017 – Bactevo, the revolutionary Cambridge, UK-based drug discovery company has received an Innovate Award for a prestigious £1.5M grant. Exploiting revolutionary work in the field of integrated, accelerated drug discovery in micro-droplets, Bactevo will progress its programmes [...]

By | January 29th, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Press Releases|

Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform

GERMANTOWN, Md., and GAITHERSBURG, Md., Jan. 24, 2017 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced that it has entered into [...]

By | January 24th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Oxitec and GBIT Announce Launch of Friendly™ Aedes Project in India

Dawalwadi (Jalna), India, and Oxford, UK, January 23rd, 2017 - Gangabishan Bhikulal Investment and Trading Limited (GBIT) and Oxitec announced today the launch of the Friendly™ Aedes project in Dawalwadi, India. Outdoor caged trials of Oxitec’s Friendly™ Aedes mosquito have [...]

By | January 24th, 2017|BioPharma & Healthcare, Disease Prevention, News, Press Releases|